ROSE Diagnostics

Funding and NIH signals

• SEC Form D raise Raised $2.21M (Form D filed Sep 15, 2026). SEC Form D 0002027716-26-000001 (Sep 15, 2026)
  Evidence (1 event)

  • Sep 15, 2026 · SEC Form D 0002027716-26-000001
    Name of Issuer: ROSE DIAGNOSTICS INC.; CIK: 2027716; Address: Carlsbad, CA; Submission type: D; Filing date: 2026-09-15; Industry Group: Other Health Care; Date of First Sale: 2026-07-10; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 2208750; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Raises and deals from press releases

• Raise Undisclosed round · $2.7M · announced Jul 17, 2026 Company release ↗
  Source quote

  • Jul 17, 2026 · Company release ↗
    “ROSE Diagnostics Inc., a pioneer in rapid, point-of-care cancer diagnostics, today announced it has raised $2.7 million in its latest round of financing”
• Raise Undisclosed round · $2.3M · announced May 14, 2025 Company release ↗
  Source quote

  • May 14, 2025 · Company release ↗
    “ROSE Diagnostics Inc., an innovative leader in rapid cancer diagnostics, today announced the successful completion of its second financing round, securing $2.3 million.”
• Raise Seed · $1M · announced Jun 27, 2024 Company release ↗
  Source quote

  • Jun 27, 2024 · Company release ↗
    “Carlsbad, California – June 27th 2024 ROSE Diagnostics, an innovative leader in rapid cancer diagnostics, today announced the successful completion of its seed round, securing $1 million through a Reg D financing”

Raises announced in these releases: $6M disclosed.

From the company’s own releases; this list is partial. All raises and deals